Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$46.98M
↑ 371% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-17.33M
Historical baseline
PeriodValueYoY Change
TTM$46.98M+168.0%
2024$-69.10M-177.0%
2023$-24.94M-20.0%
2022$-20.78M+25.2%
2021$-27.77M-10.1%
2020$-25.22M-45.2%
2019$-17.38M-48.7%
2018$-11.68M-17.4%
2017$-9.95M+26.3%
2016$-13.50M-